Back to Browse Journals » International Journal of Women's Health » Volume 2

Optimal management of perimenopausal depression

Authors Barbara L Parry

Published Date June 2010 Volume 2010:2 Pages 143—151

DOI http://dx.doi.org/10.2147/IJWH.S7155

Published 9 June 2010

Barbara L Parry

Department of Psychiatry, University of California, San Diego, USA

Abstract: Only recently has the perimenopause become recognized as a time when women are at risk for new onset and recurrence of major depression. Untreated depression at this time not only exacerbates the course of a depressive illness, but also puts women at increased risk for sleep disorders, cardiovascular disease, diabetes, and osteoporosis. Although antidepressant medication is the mainstay of treatment, adjunctive therapy, especially with estrogen replacement, may be indicated in refractory cases, and may speed the onset of antidepressant action. Many, but not all, studies, report that progesterone antagonizes the beneficial effects of estrogen. Although some antidepressants improve vasomotor symptoms, in general they are not as effective as estrogen alone for relieving these symptoms. Estrogen alone, however, does not generally result in remission of major depression in most (but not all) studies, but may provide benefit to some women with less severe symptoms if administered in therapeutic ranges. The selective serotonin reuptake inhibitors (SSRIs) in addition to estrogen are usually more beneficial in improving mood than SSRIs or estrogen treatment alone for major depression, whereas the selective norepinephrine and serotonin reuptake inhibitors do not require the addition of estrogen to exert their antidepressant effects in menopausal depression. In addition to attention to general health, hormonal status, and antidepressant treatment, the optimal management of perimenopausal depression also requires attention to the individual woman’s psychosocial and spiritual well being.
Keywords: menopause, depression, management

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

The influence of sex and gonadal hormones on sleep disorders

Orff HJ, Meliska CJ, Martinez LF, Parry BL

ChronoPhysiology and Therapy 2014, 4:15-25

Published Date: 26 June 2014

Readers of this article also read:

pH-sensitive poly(lactide-co-glycolide) nanoparticle composite microcapsules for oral delivery of insulin

Sun S, Liang N, Yamamoto H, Kawashima Y, Cui F, Yan P

International Journal of Nanomedicine 2015, 10:3489-3498

Published Date: 11 May 2015

“I am active”: effects of a program to promote active aging

Mendoza-Ruvalcaba NM, Arias-Merino ED

Clinical Interventions in Aging 2015, 10:829-837

Published Date: 5 May 2015

Differential stress reaction of human colon cells to oleic-acid-stabilized and unstabilized ultrasmall iron oxide nanoparticles

Schütz CA, Staedler D, Crosbie-Staunton K, Movia D, Chapuis Bernasconi C, Kenzaoui BH, Prina-Mello A, Juillerat-Jeanneret L

International Journal of Nanomedicine 2014, 9:3481-3498

Published Date: 23 July 2014

Therapeutic efficiency of folated poly(ethylene glycol)-chitosan-graft-polyethylenimine-Pdcd4 complexes in H-ras12V mice with liver cancer

Kim YK, Minai-Tehrani A, Lee JH, Cho CS, Cho MH, Jiang HL

International Journal of Nanomedicine 2013, 8:1489-1498

Published Date: 16 April 2013

Induction of oxidative stress, DNA damage, and apoptosis in a malignant human skin melanoma cell line after exposure to zinc oxide nanoparticles

Alarifi S, Ali D, Alkahtani S, Verma A, Ahamed M, Ahmed M, Alhadlaq HA

International Journal of Nanomedicine 2013, 8:983-993

Published Date: 7 March 2013

Retraction

Cárdenas WH, Mamani JB, Sibov TT, Caous CA, Amaro E Jr, Gamarra LF

International Journal of Nanomedicine 2012, 7:5107-5108

Published Date: 21 September 2012

Fabrication and characterization of graphene hydrogel via hydrothermal approach as a scaffold for preliminary study of cell growth

Lim HN, Huang NM, Lim SS, Harrison I, Chia CH

International Journal of Nanomedicine 2011, 6:1817-1823

Published Date: 30 August 2011

Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions

Deirdre R Pachman, Jason M Jones, Charles L Loprinzi

International Journal of Women's Health 2010, 2:123-135

Published Date: 14 May 2010